Delivery Order SPE2DB20D2104-SPE2DB25FMWRU
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $3,176.22 and a completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global...
- The Defense Logistics Agency awarded a $2,981.76 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,252.42 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and is scheduled for completion by July 25, 2025,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $40,852.26 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of July 24, 2025, with performance to take place at the vendor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used primarily in the treatment of chronic hepatitis B, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $16,140.89. This delivery order represents a firm fixed price contract with no set-aside designation, utilizing open and competitive procurement practices. The contract is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price contract, valued at $15,138.05, represents a competitive award with no set-aside designation and an ultimate completion date of July 21, 2025. The award is classified as a child contract, indicating it derives from a larger prime contract vehicle. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.28 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively to support federal medical procurement needs. The order is scheduled for completion by July 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy...
- This delivery order, valued at $14,736.15, was awarded on July 28, 2025, to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in quantities of 30 units. The contract represents a firm fixed price, competitively awarded delivery order under the Defense Logistics Agency's pharmaceutical supply chain, with a completion date of July 29, 2025. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vemlidy 25mg tablets (30-count packaging) under a firm fixed-price contract valued at $9,271.70, with completion targeted for August 15, 2025. This non-set-aside award represents a competitively awarded delivery order leveraging AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical....